Shandong Weigao Blood Purification Products Co (SHSE:603014) Total Inventories: ¥815 Mil (As of Mar. 2026)


SHSE:603014 Shandong Weigao Blood Purification Products Co Ltd SHSE:603014
38 GF Score
Price ¥35.98
! 2 Warning Signs
View Full Analysis

What is Shandong Weigao Blood Purification Products Co Total Inventories?

Shandong Weigao Blood Purification Products Co SHSE:603014 +2.36% 38 Total Inventories is ¥815 Mil as of Mar. 2026. GuruFocus rates SHSE:603014 with a GF Score™ of 38/100. The stock has 2 warning signs investors should review.

Shandong Weigao Blood Purification Products Co's total inventories for the quarter that ended in Mar. 2026 was ¥815 Mil. Shandong Weigao Blood Purification Products Co's average total inventories from the quarter that ended in Dec. 2025 to the quarter that ended in Mar. 2026 was ¥819 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Shandong Weigao Blood Purification Products Co's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was ¥6.04.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Shandong Weigao Blood Purification Products Co's Days Inventory for the three months ended in Mar. 2026 was 135.34.

Inventory Turnover measures how fast the company turns over its inventory within a year. Shandong Weigao Blood Purification Products Co's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.67.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Shandong Weigao Blood Purification Products Co's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.91.

Shandong Weigao Blood Purification Products Co  (SHSE:603014) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Shandong Weigao Blood Purification Products Co's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is

Net-Net Working Capital Per Share (Q: Mar. 2026 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(2782.106+0.75 * 899.122+0.5 * 815.122-1342.226
-0-0.013)/417.754
=6.04

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Shandong Weigao Blood Purification Products Co's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory=Average Total Inventories (Q: Mar. 2026 )/Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=819.1855/552.327*365 / 4
=135.34

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Shandong Weigao Blood Purification Products Co's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Mar. 2026 ) / Average Total Inventories (Q: Mar. 2026 )
=552.327 / 819.1855
=0.67

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Shandong Weigao Blood Purification Products Co's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=819.1855 / 904.266
=0.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Shandong Weigao Blood Purification Products Co Total Inventories Related Terms

Shandong Weigao Blood Purification Products Co Total Inventories Historical Data

* Premium members only.

The historical data trend for Shandong Weigao Blood Purification Products Co's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Weigao Blood Purification Products Co Total Inventories Chart

Shandong Weigao Blood Purification Products Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Inventories
Get a 7-Day Free Trial 561.22 661.07 1,800.28 757.07 823.25

Shandong Weigao Blood Purification Products Co Quarterly Data
Dec20 Dec21 Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 760.25 757.69 819.73 823.25 815.12
SHSE:603014
38GF Score
Shandong Weigao Blood Purification Products Co Ltd SHSE:603014
Total Inventories is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Weigao Blood Purification Products Co Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →
What does a Total Inventories of ¥815 Mil mean?
Shandong Weigao Blood Purification Products Co (SHSE:603014) has a Total Inventories of ¥815 Mil as of Mar. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Shandong Weigao Blood Purification Products Co and its competitors.
Is Shandong Weigao Blood Purification Products Co's Total Inventories too high?
Shandong Weigao Blood Purification Products Co's current Total Inventories is ¥815 Mil. Overall, Shandong Weigao Blood Purification Products Co has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Blood Purification Products Co's Total Inventories compare to ABT and SYK?
Shandong Weigao Blood Purification Products Co's Total Inventories of ¥815 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Medical Devices & Instruments company?
A good Total Inventories depends on the Medical Devices & Instruments industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Shandong Weigao Blood Purification Products Co and its competitors. Shandong Weigao Blood Purification Products Co's current Total Inventories is ¥815 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Blood Purification Products Co stock overvalued right now?
Shandong Weigao Blood Purification Products Co (SHSE:603014) has a current Total Inventories of ¥815 Mil. The current Total Inventories is ¥815 Mil. Shandong Weigao Blood Purification Products Co's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Shandong Weigao Blood Purification Products Co (SHSE:603014), the current Total Inventories is ¥815 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shandong Weigao Blood Purification Products Co Business Description

Address No. 7, Weigao West Road, Torch High-tech Industrial Development Zone, Shandong Province, Weihai, CHN, 264200
Shandong Weigao Blood Purification Products Co Ltd engaged in research and development, production and sales of blood purification medical products.
38GF Score

Get the complete analysis for SHSE:603014

Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥35.98
Price